PATH is a leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms — vaccines, drugs, diagnostics, devices and system and service innovations — that harness our entrepreneurial insight, scientific and public health expertise and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.
PATH India announced the winners of the PHC Tech Challenge today. The inaugural PHC Tech Challenge was launched in March 2021 in partnership with the Office of the Principal Scientific Adviser to the Government of India, Centre for Cellular and Molecular Platform, Social Alpha, Swasth, ACT, Stanfor... (more)
PNEUMOSIL®, a vaccine against a leading cause of deadly childhood pneumonia - the pneumococcus bacterium - has achieved prequalification by the World Health Organization (WHO). Developed through a collaboration spanning over a decade between Serum Institute of India, Pvt., Ltd. (SIIPL) and PAT... (more)
PATH welcomes the World Health Organization’s (WHO’s) prequalification of the thermostable rotavirus vaccine, ROTASIIL®, manufactured by Serum Institute of India. The vaccine, which prevents severe rotavirus-induced diarrhea in infants, provides an innovative and affordable option ... (more)
This week, the first commercially available freeze-free vaccine carrier will begin introductory field trials in Nepal. This follows the World Health Organization (WHO) announcement that the Indian-made carrier using PATH’s “Freeze-Safe” reference design passed WHO Performance, Qua... (more)
Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.’s rotavirus vaccine BRV-PV (known as ROTASIIL®) were published in the journal Vaccine. The study showed the vaccine to be safe, well tolerated, and to provide significant efficacy against severe rotav... (more)
PATH’s Defeat Diarrheal Disease Initiative (DefeatDD) convened thought leaders in New Delhi on July 26, at an event titled, “Defeating diarrhea: integration is the solution,” to deliberate on child health in India and the challenges that India faces in tackling diarrhea. (more)
Tomorrow, July 26, at 3:00 p.m. in Tamarind Hall at India Habitat Centre, PATH’s Defeat Diarrheal Disease Initiative (DefeatDD) will convene thought leaders on child health in India at an event titled,“Defeating diarrhea: Integration is the solution.”On the occasion, Dr. Ganguly, ... (more)
Thought provoking and possible game changing discussions on access, use, disposal and treatment of menstrual hygiene products in India were presented at the one day consultation: Pushing the Boundaries on the MHM Dialogue held here today.
